메뉴 건너뛰기




Volumn 47, Issue 6, 2009, Pages 571-583

Invasive mould infections: A multi-disciplinary update

Author keywords

Amphotericin B; Aspergillosis; Azoles; Echinocandins; Neutropenia; Transplantation; Zygomycosis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; BETA 1,3 GLUCAN; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; GALACTOMANNAN; ITRACONAZOLE; LIVER ENZYME; NYSTATIN; POSACONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE;

EID: 70849135958     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780902946559     Document Type: Review
Times cited : (21)

References (124)
  • 1
    • 34547927822 scopus 로고    scopus 로고
    • Invasive aspergillosis: Epidemiology, diagnosis and management in immunocompromised patients
    • Maschmeyer G, Haas A, Cornely OA. Invasive aspergillosis: Epidemiology, diagnosis and management in immunocompromised patients. Drugs 2007; 67: 1567-1601.
    • (2007) Drugs , vol.67 , pp. 1567-1601
    • Maschmeyer, G.1    Haas, A.2    Cornely, O.A.3
  • 2
    • 0036119809 scopus 로고    scopus 로고
    • The radiologic spectrum of pulmonary Aspergillus infections
    • Gotway MB, Dawn SK, Caoili EM, et al. The radiologic spectrum of pulmonary Aspergillus infections. J Comput Assist Tomogr 2002; 26: 159-173.
    • (2002) J Comput Assist Tomogr , vol.26 , pp. 159-173
    • Gotway, M.B.1    Dawn, S.K.2    Caoili, E.M.3
  • 3
    • 0035869539 scopus 로고    scopus 로고
    • Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: A prospective validation
    • Maertens J, Verhaegen J, Lagrou K, et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: A prospective validation. Blood 2001; 97: 1604-1610.
    • (2001) Blood , vol.97 , pp. 1604-1610
    • Maertens, J.1    Verhaegen, J.2    Lagrou, K.3
  • 4
    • 0035109799 scopus 로고    scopus 로고
    • Aspergillosis case-fatality rate: Systematic review of the literature
    • Lin S-J, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: Systematic review of the literature. Clin Infect Dis 2001; 32: 358-366.
    • (2001) Clin Infect Dis , vol.32 , pp. 358-366
    • Lin, S.-J.1    Schranz, J.2    Teutsch, S.M.3
  • 5
    • 0035152046 scopus 로고    scopus 로고
    • Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia
    • Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253-259.
    • (2001) J Clin Oncol , vol.19 , pp. 253-259
    • Caillot, D.1    Couaillier, J.F.2    Bernard, A.3
  • 7
    • 27644589651 scopus 로고    scopus 로고
    • Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: Impact of other therapies on outcome
    • Patterson TF, Boucher HW, Herbrecht R, et al. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: Impact of other therapies on outcome. Clin Infect Dis 2005; 41: 1448-1452.
    • (2005) Clin Infect Dis , vol.41 , pp. 1448-1452
    • Patterson, T.F.1    Boucher, H.W.2    Herbrecht, R.3
  • 8
    • 0029739907 scopus 로고    scopus 로고
    • Trends in the postmortem epidemiology of invasive fungal infections at a university hospital
    • Groll AH, Shah PM, Mentzel C, et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23-32.
    • (1996) J Infect , vol.33 , pp. 23-32
    • Groll, A.H.1    Shah, P.M.2    Mentzel, C.3
  • 9
    • 0035451130 scopus 로고    scopus 로고
    • Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997
    • McNeil MM, Nash SL, Hajjeh RA, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001; 33: 641-647.
    • (2001) Clin Infect Dis , vol.33 , pp. 641-647
    • McNeil, M.M.1    Nash, S.L.2    Hajjeh, R.A.3
  • 10
    • 2042539974 scopus 로고    scopus 로고
    • Fungal infections after marrow transplantation
    • Bowden RA, Ljungman P, Paya CV (eds). Philadelphia: Lippincott-Raven
    • Bowden RA. Fungal infections after marrow transplantation. In: Bowden RA, Ljungman P, Paya CV (eds). Transplant Infections. Philadelphia: Lippincott-Raven, 1998: 339-350.
    • (1998) Transplant Infections , pp. 339-350
    • Bowden, R.A.1
  • 11
    • 33747616462 scopus 로고    scopus 로고
    • Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: A 6-year survey
    • Cornillet A, Camus C, Nimubona S, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: A 6-year survey. Clin Infect Dis 2006; 43: 577-584.
    • (2006) Clin Infect Dis , vol.43 , pp. 577-584
    • Cornillet, A.1    Camus, C.2    Nimubona, S.3
  • 12
    • 33747055130 scopus 로고    scopus 로고
    • The epidemiology of fungal infections in patients with hematologic malignancies: The SEIFEM-2004 study
    • Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: The SEIFEM-2004 study. Haematologica 2006; 91: 1068-1075.
    • (2006) Haematologica , vol.91 , pp. 1068-1075
    • Pagano, L.1    Caira, M.2    Candoni, A.3
  • 13
    • 33745792967 scopus 로고    scopus 로고
    • Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: An autopsy study over a 15-year period (1989-2003)
    • Chamilos G, Luna M, Lewis RE, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: An autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91: 986-989.
    • (2006) Haematologica , vol.91 , pp. 986-989
    • Chamilos, G.1    Luna, M.2    Lewis, R.E.3
  • 14
    • 0037114705 scopus 로고    scopus 로고
    • Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors
    • Marr KA, Carter RA, Boeckh M, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors. Blood 2002; 100: 4358-4366.
    • (2002) Blood , vol.100 , pp. 4358-4366
    • Marr, K.A.1    Carter, R.A.2    Boeckh, M.3
  • 15
    • 0036180869 scopus 로고    scopus 로고
    • Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: Incidence and risk factors in 395 patients
    • Martino R, Subirá M, Rovira M, et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: Incidence and risk factors in 395 patients. Br J Haematol 2002; 116: 475-482.
    • (2002) Br J Haematol , vol.116 , pp. 475-482
    • Martino, R.1    Subirá, M.2    Rovira, M.3
  • 16
    • 0027483011 scopus 로고
    • Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation
    • Boland GJ, Hene RJ, Ververs C, et al. Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation. Clin Exp Immunol 1993; 94: 306-312.
    • (1993) Clin Exp Immunol , vol.94 , pp. 306-312
    • Boland, G.J.1    Hene, R.J.2    Ververs, C.3
  • 17
    • 0022462418 scopus 로고
    • Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus
    • Schrier RD, Rice GP, Oldstone MB. Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. J Infect Dis 1986; 153: 1084-1091.
    • (1986) J Infect Dis , vol.153 , pp. 1084-1091
    • Schrier, R.D.1    Rice, G.P.2    Oldstone, M.B.3
  • 18
    • 0031956205 scopus 로고    scopus 로고
    • Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients
    • Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998; 26: 753-755.
    • (1998) Clin Infect Dis , vol.26 , pp. 753-755
    • Husni, R.N.1    Gordon, S.M.2    Longworth, D.L.3
  • 19
    • 4444302605 scopus 로고    scopus 로고
    • Invasive aspergillosis in critically ill patients without malignancy
    • Meersseman W, Vandecasteele SJ, Wilmer A, et al. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170: 621-625.
    • (2004) Am J Respir Crit Care Med , vol.170 , pp. 621-625
    • Meersseman, W.1    Vandecasteele, S.J.2    Wilmer, A.3
  • 20
    • 17644370312 scopus 로고    scopus 로고
    • Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients
    • Chandrasekar PH, Ito JI. Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients. Clin Infect Dis 2005; 40(Suppl. 6): S392-S400.
    • (2005) Clin Infect Dis , vol.40 , Issue.SUPPL. 6
    • Chandrasekar, P.H.1    Ito, J.I.2
  • 21
    • 0347480117 scopus 로고    scopus 로고
    • Epidemiology of Aspergillus terreus at a university hospital
    • Baddley JW, Pappas PG, Smith AC, et al. Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol 2003; 41: 5525-5529.
    • (2003) J Clin Microbiol , vol.41 , pp. 5525-5529
    • Baddley, J.W.1    Pappas, P.G.2    Smith, A.C.3
  • 22
    • 0033026744 scopus 로고    scopus 로고
    • In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole
    • Sutton DA, Sanche SE, Revankar SG, et al. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol 1999; 37: 2343-2345.
    • (1999) J Clin Microbiol , vol.37 , pp. 2343-2345
    • Sutton, D.A.1    Sanche, S.E.2    Revankar, S.G.3
  • 23
    • 4844228685 scopus 로고    scopus 로고
    • Aspergillus terreus: An emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies
    • Hachem RY, Kontoyiannis DP, Boktour MR, et al. Aspergillus terreus: An emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer 2004; 101: 1594-1600.
    • (2004) Cancer , vol.101 , pp. 1594-1600
    • Hachem, R.Y.1    Kontoyiannis, D.P.2    Boktour, M.R.3
  • 24
    • 0031901306 scopus 로고    scopus 로고
    • Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature
    • Iwen PC, Rupp ME, Langnas AN, et al. Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin Infect Dis 1998; 26: 1092-1097.
    • (1998) Clin Infect Dis , vol.26 , pp. 1092-1097
    • Iwen, P.C.1    Rupp, M.E.2    Langnas, A.N.3
  • 25
    • 23844464106 scopus 로고    scopus 로고
    • Epidemiology and outcome of zygomycosis: A review of 929 reported cases
    • Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653.
    • (2005) Clin Infect Dis , vol.41 , pp. 634-653
    • Roden, M.M.1    Zaoutis, T.E.2    Buchanan, W.L.3
  • 26
    • 20144389423 scopus 로고    scopus 로고
    • Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: A case-control observational study of 27 recent cases
    • Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: A case-control observational study of 27 recent cases. J Infect Dis 2005; 191: 1350-1360.
    • (2005) J Infect Dis , vol.191 , pp. 1350-1360
    • Kontoyiannis, D.P.1    Lionakis, M.S.2    Lewis, R.E.3
  • 27
    • 4444227169 scopus 로고    scopus 로고
    • Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole
    • Imhof A, Balajee SA, Fredricks DN, et al. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004; 39: 743-746.
    • (2004) Clin Infect Dis , vol.39 , pp. 743-746
    • Imhof, A.1    Balajee, S.A.2    Fredricks, D.N.3
  • 28
    • 27444447144 scopus 로고    scopus 로고
    • Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study
    • Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study. Clin Infect Dis 2005; 41: 1242-1250.
    • (2005) Clin Infect Dis , vol.41 , pp. 1242-1250
    • Maertens, J.1    Theunissen, K.2    Verhoef, G.3
  • 29
    • 1642545694 scopus 로고    scopus 로고
    • Invasive aspergillosis: Current and future challenges in diagnosis and therapy
    • Hope WW, Denning DW. Invasive aspergillosis: Current and future challenges in diagnosis and therapy. Clin Microbiol Infect 2004; 10: 2-4.
    • (2004) Clin Microbiol Infect , vol.10 , pp. 2-4
    • Hope, W.W.1    Denning, D.W.2
  • 30
    • 0033037922 scopus 로고    scopus 로고
    • Invasive aspergillosis in transplant patients
    • Paterson DL, Singh N. Invasive aspergillosis in transplant patients. Medicine 1999; 78: 123-138.
    • (1999) Medicine , vol.78 , pp. 123-138
    • Paterson, D.L.1    Singh, N.2
  • 31
    • 12944291020 scopus 로고    scopus 로고
    • Aspergillus infections in transplant recipients
    • Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18: 44-69.
    • (2005) Clin Microbiol Rev , vol.18 , pp. 44-69
    • Singh, N.1    Paterson, D.L.2
  • 32
    • 33846418017 scopus 로고    scopus 로고
    • Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign
    • Greene RE, Schlamm HT, Oestmann JW, et al. Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign. Clin Infect Dis 2007; 44: 373-379.
    • (2007) Clin Infect Dis , vol.44 , pp. 373-379
    • Greene, R.E.1    Schlamm, H.T.2    Oestmann, J.W.3
  • 33
    • 20844456625 scopus 로고    scopus 로고
    • Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer
    • Chamilos G, Marom EM, Lewis RE, et al. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 2005; 41: 60-66.
    • (2005) Clin Infect Dis , vol.41 , pp. 60-66
    • Chamilos, G.1    Marom, E.M.2    Lewis, R.E.3
  • 34
    • 0032856762 scopus 로고    scopus 로고
    • Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis
    • Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol 1999; 37: 3223-3228.
    • (1999) J Clin Microbiol , vol.37 , pp. 3223-3228
    • Maertens, J.1    Verhaegen, J.2    Demuynck, H.3
  • 35
    • 0028821064 scopus 로고
    • A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis
    • Stynen D, Goris A, Sarfati J, et al. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995; 33: 497-500.
    • (1995) J Clin Microbiol , vol.33 , pp. 497-500
    • Stynen, D.1    Goris, A.2    Sarfati, J.3
  • 36
    • 0031811110 scopus 로고    scopus 로고
    • Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis
    • Bretagne S, Costa J-M, Bart-Delabesse E, et al. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis 1998; 26: 1407-1412.
    • (1998) Clin Infect Dis , vol.26 , pp. 1407-1412
    • Bretagne, S.1    Costa, J.-M.2    Bart-Delabesse, E.3
  • 37
    • 0031953002 scopus 로고    scopus 로고
    • Comparison of an enzyme immunoassay and a latex aggregation system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients
    • Machetti M, Feasi M, Mordini N, et al. Comparison of an enzyme immunoassay and a latex aggregation system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients. Bone Marrow Transplant 1998; 21: 917-921.
    • (1998) Bone Marrow Transplant , vol.21 , pp. 917-921
    • MacHetti, M.1    Feasi, M.2    Mordini, N.3
  • 38
    • 0029872641 scopus 로고    scopus 로고
    • Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: Early predictive value and clinical use in invasive aspergillosis
    • Rohrlich P, Sarfati J, Mariani P, et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: Early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996; 15: 232-237.
    • (1996) Pediatr Infect Dis J , vol.15 , pp. 232-237
    • Rohrlich, P.1    Sarfati, J.2    Mariani, P.3
  • 39
    • 0034584615 scopus 로고    scopus 로고
    • Surveillance of Aspergillus galactomannan anitgenemia for invasive aspergillosis by enzyme-linked immunosorbant assay in neutropenic patients treated for haematological malignancies
    • Ulusakarya A, Chachaty E, Vantelon J-M, et al. Surveillance of Aspergillus galactomannan anitgenemia for invasive aspergillosis by enzyme-linked immunosorbant assay in neutropenic patients treated for haematological malignancies. Hematol J 2000; 1: 111-116.
    • (2000) Hematol J , vol.1 , pp. 111-116
    • Ulusakarya, A.1    Chachaty, E.2    Vantelon, J.-M.3
  • 40
    • 0029027681 scopus 로고
    • Sandwich enzymelinked immunosorbant assay compared with Pastorex latex agglutination test for diagnosing invasive aspergilloisis in immunocompromised patients
    • Verweij PE, Stynen D, Rijs AMMM, et al. Sandwich enzymelinked immunosorbant assay compared with Pastorex latex agglutination test for diagnosing invasive aspergilloisis in immunocompromised patients. J Clin Microbiol 1995; 33: 1912-1914.
    • (1995) J Clin Microbiol , vol.33 , pp. 1912-1914
    • Verweij, P.E.1    Stynen, D.2    Ammm, R.3
  • 41
    • 0028970792 scopus 로고
    • Plasma (1-3)-beta- D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis
    • Miyazaki T, Kohno S, Mitsutake K, et al. Plasma (1-3)-beta- D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol 1995; 33: 3115-3118.
    • (1995) J Clin Microbiol , vol.33 , pp. 3115-3118
    • Miyazaki, T.1    Kohno, S.2    Mitsutake, K.3
  • 42
    • 0028983695 scopus 로고
    • Plasma (1-3)-b-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes
    • Obayashi T, Yoshida M, Mori T, et al. Plasma (1-3)-b-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17-20.
    • (1995) Lancet , vol.345 , pp. 17-20
    • Obayashi, T.1    Yoshida, M.2    Mori, T.3
  • 43
    • 84907126433 scopus 로고
    • Determination of plasma (1-3)-b-D-glucan: A new diagnosis aid to deep mycosis
    • Obayashi T, Yoshida M, Tamura H, et al. Determination of plasma (1-3)-b-D-glucan: A new diagnosis aid to deep mycosis. J Med Vet Mycol 1992; 30: 275-280.
    • (1992) J Med Vet Mycol , vol.30 , pp. 275-280
    • Obayashi, T.1    Yoshida, M.2    Tamura, H.3
  • 44
    • 0029871161 scopus 로고    scopus 로고
    • Evaluation of the diagnostic value of the measurement of (1-3)-b-D-glucan in patients with pulmonary aspergillosis
    • Yuasa K, Goto H, Iguchi M, et al. Evaluation of the diagnostic value of the measurement of (1-3)-b-D-glucan in patients with pulmonary aspergillosis. Respiration 1996; 63: 78-83.
    • (1996) Respiration , vol.63 , pp. 78-83
    • Yuasa, K.1    Goto, H.2    Iguchi, M.3
  • 45
    • 40749151917 scopus 로고    scopus 로고
    • 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia
    • Senn L, Robinson JO, Schmidt S, et al. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008; 46: 878-885.
    • (2008) Clin Infect Dis , vol.46 , pp. 878-885
    • Senn, L.1    Robinson, J.O.2    Schmidt, S.3
  • 46
    • 0031058641 scopus 로고    scopus 로고
    • Detection of Aspergillus DNA in bronchoalveolar lavage fluid of AIDS patients by the polymerase chain reaction [letter]
    • Bart-Delabesse E, Marmorat-Khuong A, Costa JM, et al. Detection of Aspergillus DNA in bronchoalveolar lavage fluid of AIDS patients by the polymerase chain reaction [letter]. Eur J Clin Microbiol Infect Dis 1997; 16: 24-25.
    • (1997) Eur J Clin Microbiol Infect Dis , vol.16 , pp. 24-25
    • Bart-Delabesse, E.1    Marmorat-Khuong, A.2    Costa, J.M.3
  • 47
    • 0035882177 scopus 로고    scopus 로고
    • Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: Clinical results
    • Buchheidt D, Baust C, Skladny H, et al. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: Clinical results. Clin Infect Dis 2001; 33: 428-435.
    • (2001) Clin Infect Dis , vol.33 , pp. 428-435
    • Buchheidt, D.1    Baust, C.2    Skladny, H.3
  • 48
    • 0037114694 scopus 로고    scopus 로고
    • Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individual and patients with haematological malignancies
    • Hebart H, Bollinger C, Fisch P, et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individual and patients with haematological malignancies. Blood 2003; 100: 4521-4528.
    • (2003) Blood , vol.100 , pp. 4521-4528
    • Hebart, H.1    Bollinger, C.2    Fisch, P.3
  • 49
    • 0035502916 scopus 로고    scopus 로고
    • Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis
    • Kami M, Fukui T, Ogawa S, et al. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 2001; 33: 1504-1512.
    • (2001) Clin Infect Dis , vol.33 , pp. 1504-1512
    • Kami, M.1    Fukui, T.2    Ogawa, S.3
  • 50
    • 0037090212 scopus 로고    scopus 로고
    • Polymerase chain reaction detection of Aspergillus DNA in experimental models of invasive aspergillosis
    • Loeffler J, Kloepfer K, Hebart H, et al. Polymerase chain reaction detection of Aspergillus DNA in experimental models of invasive aspergillosis. J Infect Dis 2002; 185: 1203-1206.
    • (2002) J Infect Dis , vol.185 , pp. 1203-1206
    • Loeffler, J.1    Kloepfer, K.2    Hebart, H.3
  • 53
    • 4644346490 scopus 로고    scopus 로고
    • Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
    • Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391-1402.
    • (2004) N Engl J Med , vol.351 , pp. 1391-1402
    • Walsh, T.J.1    Teppler, H.2    Donowitz, G.R.3
  • 54
    • 39449095735 scopus 로고    scopus 로고
    • Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America
    • Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-360.
    • (2008) Clin Infect Dis , vol.46 , pp. 327-360
    • Walsh, T.J.1    Anaissie, E.J.2    Denning, D.W.3
  • 55
    • 34547546151 scopus 로고    scopus 로고
    • Empirical antifungal therapy in neutropaenic cancer patients with persistent fever
    • Marchetti O, Cordonnier C, Calandra T. Empirical antifungal therapy in neutropaenic cancer patients with persistent fever. Eur J Cancer Supplements 2007; 5: 32-42.
    • (2007) Eur J Cancer Supplements , vol.5 , pp. 32-42
    • Marchetti, O.1    Cordonnier, C.2    Calandra, T.3
  • 56
    • 34547513219 scopus 로고    scopus 로고
    • Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients
    • Herbrecht R, Flückinger U, Gachot B, et al. Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients. Eur J Cancer Supplements 2007; 5: 49-59.
    • (2007) Eur J Cancer Supplements , vol.5 , pp. 49-59
    • Herbrecht, R.1    Flückinger, U.2    Gachot, B.3
  • 57
    • 0038681693 scopus 로고    scopus 로고
    • Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole
    • Ullmann AJ. Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole. Curr Med Res Opin 2003; 19: 263-271.
    • (2003) Curr Med Res Opin , vol.19 , pp. 263-271
    • Ullmann, A.J.1
  • 58
    • 34248160575 scopus 로고    scopus 로고
    • Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
    • Cornely OA, Maertens J, Bresnik M, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 2007; 44: 1289-1297.
    • (2007) Clin Infect Dis , vol.44 , pp. 1289-1297
    • Cornely, O.A.1    Maertens, J.2    Bresnik, M.3
  • 59
    • 33749509216 scopus 로고    scopus 로고
    • Defining clinical failure for salvage studies
    • Maschmeyer G, Haas A. Defining clinical failure for salvage studies. Med Mycol 2006; 44: S315-S318.
    • (2006) Med Mycol , vol.44
    • Maschmeyer, G.1    Haas, A.2
  • 60
    • 42549154420 scopus 로고    scopus 로고
    • When primary antifungal therapy fails
    • Nucci M, Perfect JR. When primary antifungal therapy fails. Clin Infect Dis 2008; 46: 1426-1433
    • (2008) Clin Infect Dis , vol.46 , pp. 1426-1433
    • Nucci, M.1    Perfect, J.R.2
  • 61
    • 59749106012 scopus 로고    scopus 로고
    • Antifungal therapeutic drug monitoring: Established and emerging indications
    • Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: Established and emerging indications. Antimicrob Agents Chemother 2009; 53: 24-34.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 24-34
    • Andes, D.1    Pascual, A.2    Marchetti, O.3
  • 62
    • 35348984218 scopus 로고    scopus 로고
    • Voriconazole: A broad spectrum triazole for the treatment of serious and invasive fungal infections
    • Maschmeyer G, Haas A. Voriconazole: A broad spectrum triazole for the treatment of serious and invasive fungal infections. Future Microbiol 2006; 1: 365-385.
    • (2006) Future Microbiol , vol.1 , pp. 365-385
    • Maschmeyer, G.1    Haas, A.2
  • 63
    • 34248525128 scopus 로고    scopus 로고
    • Immune reconstitution syndrome associated with opportunistic mycoses
    • DOI 10.1016/S1473-3099(07)70085-3, PII S1473309907700853
    • Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis 2007; 7: 395-401. (Pubitemid 46765196)
    • (2007) Lancet Infectious Diseases , vol.7 , Issue.6 , pp. 395-401
    • Singh, N.1    Perfect, J.R.2
  • 64
    • 9644284471 scopus 로고    scopus 로고
    • Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy
    • Maertens J, Raad I, Petrikkos G, et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004; 39: 1563-1571.
    • (2004) Clin Infect Dis , vol.39 , pp. 1563-1571
    • Maertens, J.1    Raad, I.2    Petrikkos, G.3
  • 65
    • 33845710284 scopus 로고    scopus 로고
    • Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
    • Walsh TJ, Raad I, Patterson TF, et al. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial. Clin Infect Dis 2007; 44: 2-12.
    • (2007) Clin Infect Dis , vol.44 , pp. 2-12
    • Walsh, T.J.1    Raad, I.2    Patterson, T.F.3
  • 66
    • 0037398897 scopus 로고    scopus 로고
    • Efficacy and safety of amphotericin B lipid complex for zygomycosis
    • Larkin JA, Montero JA. Efficacy and safety of amphotericin B lipid complex for zygomycosis. Infect Med 2003; 20: 201-206.
    • (2003) Infect Med , vol.20 , pp. 201-206
    • Larkin, J.A.1    Montero, J.A.2
  • 67
    • 33744463904 scopus 로고    scopus 로고
    • Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases
    • van Burik JA, Hare RS, Solomon HF, et al. Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases. Clin Infect Dis 2006; 42: E61-e65.
    • (2006) Clin Infect Dis , vol.42
    • Van Burik, J.A.1    Hare, R.S.2    Solomon, H.F.3
  • 68
    • 63649156819 scopus 로고    scopus 로고
    • Empirical versus preemptive antifungal therapy for high risk, febrile, neutropenic patients: A randomized, controlled trial
    • Cordonnier C, Pautas C, Maury S, et al. Empirical versus preemptive antifungal therapy for high risk, febrile, neutropenic patients: A randomized, controlled trial. Clin Infect Dis 2009; 48: 1042-1051.
    • (2009) Clin Infect Dis , vol.48 , pp. 1042-1051
    • Cordonnier, C.1    Pautas, C.2    Maury, S.3
  • 69
    • 0028997086 scopus 로고
    • Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation- a prospective, randomized, double-blind study
    • Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation- a prospective, randomized, double-blind study. J Infect Dis 1995; 171: 1545-1552.
    • (1995) J Infect Dis , vol.171 , pp. 1545-1552
    • Slavin, M.A.1    Osborne, B.2    Adams, R.3
  • 70
    • 0034665657 scopus 로고    scopus 로고
    • Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: Long-term follow-up of a randomized, placebo-controlled trial
    • Marr KA, Seidel K, Slavin MA, et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: Long-term follow-up of a randomized, placebo-controlled trial. Blood 2000; 96: 2055-2061.
    • (2000) Blood , vol.96 , pp. 2055-2061
    • Marr, K.A.1    Seidel, K.2    Slavin, M.A.3
  • 71
    • 0026597735 scopus 로고
    • A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
    • Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845-851.
    • (1992) N Engl J Med , vol.326 , pp. 845-851
    • Goodman, J.L.1    Winston, D.J.2    Greenfield, R.A.3
  • 72
    • 0029090675 scopus 로고
    • Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias
    • Schaffner A, Schaffner M. Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias. J Infect Dis 1995; 172: 1035-1041.
    • (1995) J Infect Dis , vol.172 , pp. 1035-1041
    • Schaffner, A.1    Schaffner, M.2
  • 73
    • 0033014809 scopus 로고    scopus 로고
    • Randomized placebocontrolled trial of fluconazole prophylaxis for neutropenic cancer patients: Benefit based on purpose and intensity of cytotoxic therapy
    • The Canadian Fluconazole Prophylaxis Study Group
    • Rotstein C, Bow EJ, Laverdiere M, et al. Randomized placebocontrolled trial of fluconazole prophylaxis for neutropenic cancer patients: Benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clin Infect Dis 1999; 28: 331-340.
    • (1999) Clin Infect Dis , vol.28 , pp. 331-340
    • Rotstein, C.1    Bow, E.J.2    Laverdiere, M.3
  • 74
    • 31544444209 scopus 로고    scopus 로고
    • An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia
    • Glasmacher A, Cornely O, Ullmann AJ, et al. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. J Antimicrob Chemother 2006; 57: 317-325.
    • (2006) J Antimicrob Chemother , vol.57 , pp. 317-325
    • Glasmacher, A.1    Cornely, O.2    Ullmann, A.J.3
  • 75
    • 33846462456 scopus 로고    scopus 로고
    • Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
    • Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356: 348-359.
    • (2007) N Engl J Med , vol.356 , pp. 348-359
    • Cornely, O.A.1    Maertens, J.2    Winston, D.J.3
  • 76
    • 33846410666 scopus 로고    scopus 로고
    • Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
    • Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335-347.
    • (2007) N Engl J Med , vol.356 , pp. 335-347
    • Ullmann, A.J.1    Lipton, J.H.2    Vesole, D.H.3
  • 77
    • 0035173979 scopus 로고    scopus 로고
    • Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans
    • Marr KA, Lyons CN, Ha K, et al. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Antimicrob Agents Chemother 2001; 45: 52-59.
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 52-59
    • Marr, K.A.1    Lyons, C.N.2    Ha, K.3
  • 78
    • 0029113723 scopus 로고
    • Antifungal prophylaxis in patients with hematologic malignancies: A reappraisal
    • Uzun O, Anaissie EJ. Antifungal prophylaxis in patients with hematologic malignancies: A reappraisal. Blood 1995; 86: 2063-2072.
    • (1995) Blood , vol.86 , pp. 2063-2072
    • Uzun, O.1    Anaissie, E.J.2
  • 79
    • 18844441252 scopus 로고    scopus 로고
    • Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli
    • Lionakis MS, Lewis RE, Torres HA, et al. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Microbiol Infect Dis 2005; 52: 15-20.
    • (2005) Diagn Microbiol Infect Dis , vol.52 , pp. 15-20
    • Lionakis, M.S.1    Lewis, R.E.2    Torres, H.A.3
  • 82
    • 2442670429 scopus 로고    scopus 로고
    • Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients
    • Cordonnier C, Maury S, Pautas C, et al. Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients. Bone Marrow Transplant 2004; 33: 943-948.
    • (2004) Bone Marrow Transplant , vol.33 , pp. 943-948
    • Cordonnier, C.1    Maury, S.2    Pautas, C.3
  • 83
    • 41149123494 scopus 로고    scopus 로고
    • Risk factors for breakthrough invasive fungal infection during secondary prophylaxis
    • Multinational Case Registry of the Infectious DiseasesWorking Party of the German Society for Hematology and Oncology
    • Cornely OA, Böhme A, Reichert D, et al. Multinational Case Registry of the Infectious DiseasesWorking Party of the German Society for Hematology and Oncology. Risk factors for breakthrough invasive fungal infection during secondary prophylaxis. J Antimicrob Chemother 2008; 61: 939-946.
    • (2008) J Antimicrob Chemother , vol.61 , pp. 939-946
    • Cornely, O.A.1    Böhme, A.2    Reichert, D.3
  • 84
    • 0037337591 scopus 로고    scopus 로고
    • Aspergillus infections after lung transplantation: Clinical differences in type of transplant and implications for management
    • Singh N, Husain S. Aspergillus infections after lung transplantation: Clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003; 22: 258-266.
    • (2003) J Heart Lung Transplant , vol.22 , pp. 258-266
    • Singh, N.1    Husain, S.2
  • 85
    • 0034566748 scopus 로고    scopus 로고
    • Anastomotic infections in lung transplant recipients
    • Hadjiliadis D, Howell DN, Davis RD, et al. Anastomotic infections in lung transplant recipients. Ann Transplant 2000; 5: 13-19.
    • (2000) Ann Transplant , vol.5 , pp. 13-19
    • Hadjiliadis, D.1    Howell, D.N.2    Davis, R.D.3
  • 86
    • 2342456301 scopus 로고    scopus 로고
    • Airway anastomosis complications in de novo lung transplantation with sirolimusbased immunosuppression
    • Groetzner J, Kur F, Spelsberg F, et al. Airway anastomosis complications in de novo lung transplantation with sirolimusbased immunosuppression. J Heart Lung Transplant 2004; 23: 632-638.
    • (2004) J Heart Lung Transplant , vol.23 , pp. 632-638
    • Groetzner, J.1    Kur, F.2    Spelsberg, F.3
  • 87
    • 0030910373 scopus 로고    scopus 로고
    • Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression
    • Selby R, Ramirez CB, Singh R, et al. Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression. Arch Surg 1997; 132: 304-310.
    • (1997) Arch Surg , vol.132 , pp. 304-310
    • Selby, R.1    Ramirez, C.B.2    Singh, R.3
  • 89
    • 0037235092 scopus 로고    scopus 로고
    • Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients
    • Singh N, Avery RK, Munoz P, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003; 36: 46-52.
    • (2003) Clin Infect Dis , vol.36 , pp. 46-52
    • Singh, N.1    Avery, R.K.2    Munoz, P.3
  • 90
    • 33750020257 scopus 로고    scopus 로고
    • Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: Where will MELD lead us?
    • Gonwa TA, McBride MA, Anderson K, et al. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: Where will MELD lead us? Am J Transplant 2006; 6: 2651-2659.
    • (2006) Am J Transplant , vol.6 , pp. 2651-2659
    • Gonwa, T.A.1    McBride, M.A.2    Anderson, K.3
  • 91
    • 0036852162 scopus 로고    scopus 로고
    • Risk factors for invasive aspergillosis in liver transplant recipients
    • Fortún J, Martín-Dávila P, Moreno S, et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl 2002; 8: 1065-1070.
    • (2002) Liver Transpl , vol.8 , pp. 1065-1070
    • Fortún, J.1    Martín-Dávila, P.2    Moreno, S.3
  • 92
    • 0034090029 scopus 로고    scopus 로고
    • Invasive mycoses in organ transplant recipients: Controversies in prophylaxis and management
    • Singh N. Invasive mycoses in organ transplant recipients: Controversies in prophylaxis and management. J Antimicrob Chemother 2000; 45: 749-755. (Pubitemid 30348942)
    • (2000) Journal of Antimicrobial Chemotherapy , vol.45 , Issue.6 , pp. 749-755
    • Singh, N.1
  • 94
    • 0041766322 scopus 로고    scopus 로고
    • Opportunistic mycelial fungal infections in organ transplant recipients: Emerging importance of non-Aspergillus mycelial fungi
    • Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: Emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003; 37: 221-229.
    • (2003) Clin Infect Dis , vol.37 , pp. 221-229
    • Husain, S.1    Alexander, B.D.2    Munoz, P.3
  • 95
    • 33646455889 scopus 로고    scopus 로고
    • Antifungal prophylaxis in liver transplant patients: A systematic review and meta-analysis
    • Cruciani M, Mengoli C, Malena M, et al. Antifungal prophylaxis in liver transplant patients: A systematic review and meta-analysis. Liver Transpl 2006; 12: 850-858.
    • (2006) Liver Transpl , vol.12 , pp. 850-858
    • Cruciani, M.1    Mengoli, C.2    Malena, M.3
  • 96
    • 10744231098 scopus 로고    scopus 로고
    • Prevention of invasive fungal infections in liver transplant recipients: The role of prophylaxis with lipid formulations of amphotericin B in high-risk patients
    • Fortún J, Martín-Davila P, Moreno S, et al. Prevention of invasive fungal infections in liver transplant recipients: The role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemother 2003; 52: 813-819.
    • (2003) J Antimicrob Chemother , vol.52 , pp. 813-819
    • Fortún, J.1    Martín-Davila, P.2    Moreno, S.3
  • 97
    • 21044444050 scopus 로고    scopus 로고
    • Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation
    • Hellinger WC, Bonatti H, Yao JD, et al. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation. Liver Transpl 2005; 11: 656-662.
    • (2005) Liver Transpl , vol.11 , pp. 656-662
    • Hellinger, W.C.1    Bonatti, H.2    Yao, J.D.3
  • 99
    • 38149060052 scopus 로고    scopus 로고
    • Antifungal management practices in liver transplant recipients
    • Singh N, Wagener MM, Cacciarelli TV, et al. Antifungal management practices in liver transplant recipients. Am J Transplant 2008; 8: 426-431.
    • (2008) Am J Transplant , vol.8 , pp. 426-431
    • Singh, N.1    Wagener, M.M.2    Cacciarelli, T.V.3
  • 100
    • 32844474763 scopus 로고    scopus 로고
    • Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: A prospective, multicenter, observational study
    • Singh N, Limaye AP, Forrest G, et al. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: A prospective, multicenter, observational study. Transplantation 2006; 81: 320-326.
    • (2006) Transplantation , vol.81 , pp. 320-326
    • Singh, N.1    Limaye, A.P.2    Forrest, G.3
  • 101
    • 20244377989 scopus 로고    scopus 로고
    • Aspergillus infections in lung transplant recipients: Risk factors and outcome
    • Solé A, Morant P, Salavert M, et al. Aspergillus infections in lung transplant recipients: Risk factors and outcome. Clin Microbiol Infect 2005; 11: 359-365.
    • (2005) Clin Microbiol Infect , vol.11 , pp. 359-365
    • Solé, A.1    Morant, P.2    Salavert, M.3
  • 102
    • 0033512462 scopus 로고    scopus 로고
    • Aspergillosis in children with cancer: A 34-year experience
    • Abbasi S, Shenep JL, Hughes WT, et al. Aspergillosis in children with cancer: A 34-year experience. Clin Infect Dis 1999; 29: 1210-1219.
    • (1999) Clin Infect Dis , vol.29 , pp. 1210-1219
    • Abbasi, S.1    Shenep, J.L.2    Hughes, W.T.3
  • 103
    • 33646377166 scopus 로고    scopus 로고
    • Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000
    • Zaoutis TE, Heydon K, Chu JH, et al. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 2006; 117: E711-e716.
    • (2006) Pediatrics , vol.117
    • Zaoutis, T.E.1    Heydon, K.2    Chu, J.H.3
  • 104
    • 0031829724 scopus 로고    scopus 로고
    • Lipid formulations of amphotericin B: Clinical perspectives for the management of invasive fungal infections in children with cancer
    • Groll AH, Mü ller FM, Piscitelli SC, et al. Lipid formulations of amphotericin B: Clinical perspectives for the management of invasive fungal infections in children with cancer. Klin Padiatr 1998; 210: 264-273.
    • (1998) Klin Padiatr , vol.210 , pp. 264-273
    • Groll, A.H.1    Mü Ller, F.M.2    Piscitelli, S.C.3
  • 105
    • 0032927754 scopus 로고    scopus 로고
    • Candida infection in pediatric liver transplant recipients
    • Gladdy RA, Richardson SE, Davies HD, et al. Candida infection in pediatric liver transplant recipients. Liver Transpl Surg 1999; 5: 16-24.
    • (1999) Liver Transpl Surg , vol.5 , pp. 16-24
    • Gladdy, R.A.1    Richardson, S.E.2    Davies, H.D.3
  • 106
    • 0031261166 scopus 로고    scopus 로고
    • Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation
    • Ringdén O, Andström EE, Remberger M, et al. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation. Pediatr Transplant 1997; 1: 124-129.
    • (1997) Pediatr Transplant , vol.1 , pp. 124-129
    • Ringdén, O.1    Andström, E.E.2    Remberger, M.3
  • 107
    • 0033757977 scopus 로고    scopus 로고
    • Invasive fungal infections in pediatric bone marrow transplant recipients: Single center experience of 10 years
    • Hovi L, Saarinen-Pihkala UM, Vettenranta K, et al. Invasive fungal infections in pediatric bone marrow transplant recipients: Single center experience of 10 years. Bone Marrow Transplant 2000; 26: 999-1004.
    • (2000) Bone Marrow Transplant , vol.26 , pp. 999-1004
    • Hovi, L.1    Saarinen-Pihkala, U.M.2    Vettenranta, K.3
  • 108
    • 0036191021 scopus 로고    scopus 로고
    • Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
    • Walsh TJ, Lutsar I, Driscoll T, et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 2002; 21: 240-248.
    • (2002) Pediatr Infect Dis J , vol.21 , pp. 240-248
    • Walsh, T.J.1    Lutsar, I.2    Driscoll, T.3
  • 109
    • 2542443542 scopus 로고    scopus 로고
    • Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration
    • Walsh TJ, Karlsson MO, Driscoll T, et al. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrob Agents Chemother 2004; 48: 2166-2172.
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 2166-2172
    • Walsh, T.J.1    Karlsson, M.O.2    Driscoll, T.3
  • 110
    • 27744510163 scopus 로고    scopus 로고
    • New antifungal agents under development in children and neonates
    • Steinbach WJ, Benjamin DK. New antifungal agents under development in children and neonates. Curr Opin Infect Dis 2005; 18: 484-489.
    • (2005) Curr Opin Infect Dis , vol.18 , pp. 484-489
    • Steinbach, W.J.1    Benjamin, D.K.2
  • 111
    • 0032806739 scopus 로고    scopus 로고
    • Amphotericin B lipid complex in pediatric patients with invasive fungal infections
    • Walsh TJ, Seibel NL, Arndt C, et al. Amphotericin B lipid complex in pediatric patients with invasive fungal infections. Pediatr Infect Dis J 1999; 18: 702-708.
    • (1999) Pediatr Infect Dis J , vol.18 , pp. 702-708
    • Walsh, T.J.1    Seibel, N.L.2    Arndt, C.3
  • 112
    • 0035088410 scopus 로고    scopus 로고
    • Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients
    • Herbrecht R, Auvrignon A, Andrès E, et al. Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients. Eur J Clin Microbiol Infect Dis 2001; 20: 77-82.
    • (2001) Eur J Clin Microbiol Infect Dis , vol.20 , pp. 77-82
    • Herbrecht, R.1    Auvrignon, A.2    Andrès, E.3
  • 113
    • 13844298286 scopus 로고    scopus 로고
    • Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections
    • Wiley JM, Seibel NL, Walsh TJ. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections. Pediatr Infect Dis J 2005; 24: 167-174.
    • (2005) Pediatr Infect Dis J , vol.24 , pp. 167-174
    • Wiley, J.M.1    Seibel, N.L.2    Walsh, T.J.3
  • 114
    • 0028329540 scopus 로고
    • Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis
    • Beyer J, Schwartz S, Barzen G, et al. Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis. Infection 1994; 22: 143-148.
    • (1994) Infection , vol.22 , pp. 143-148
    • Beyer, J.1    Schwartz, S.2    Barzen, G.3
  • 115
    • 0030898349 scopus 로고    scopus 로고
    • Significant reduction in the number of fungal infections after lung-, heartlung, and heart transplantation using aerosolized amphotericin B prophylaxis
    • Reichenspurner H, Gamberg P, Nitschke M, et al. Significant reduction in the number of fungal infections after lung-, heartlung, and heart transplantation using aerosolized amphotericin B prophylaxis. Transplant Proc 1997; 29: 627-628.
    • (1997) Transplant Proc , vol.29 , pp. 627-628
    • Reichenspurner, H.1    Gamberg, P.2    Nitschke, M.3
  • 116
    • 0033152309 scopus 로고    scopus 로고
    • Aerosolized amphotericin B inhalations as prophylaxis of invasive Aspergillus infections during prolonged neutropenia: Results of a prospective randomized multicenter trial
    • Schwartz S, Behre G, Heinemann V, et al. Aerosolized amphotericin B inhalations as prophylaxis of invasive Aspergillus infections during prolonged neutropenia: Results of a prospective randomized multicenter trial. Blood 1999; 93: 3654-3661.
    • (1999) Blood , vol.93 , pp. 3654-3661
    • Schwartz, S.1    Behre, G.2    Heinemann, V.3
  • 117
  • 119
    • 0035881350 scopus 로고    scopus 로고
    • Safety of aerosolized amphotericin B lipid complex in lung transplant recipients
    • Palmer SM, Drew RH, Whitehouse JD, et al. Safety of aerosolized amphotericin B lipid complex in lung transplant recipients. Transplantation 2001; 72: 545-548.
    • (2001) Transplantation , vol.72 , pp. 545-548
    • Palmer, S.M.1    Drew, R.H.2    Whitehouse, J.D.3
  • 120
    • 0742287242 scopus 로고    scopus 로고
    • Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lungtransplant recipients
    • Drew RH, Dodds Ashley E, Benjamin DK Jr, et al. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lungtransplant recipients. Transplantation 2004; 77: 232-237.
    • (2004) Transplantation , vol.77 , pp. 232-237
    • Drew, R.H.1    Dodds Ashley, E.2    Benjamin Jr., D.K.3
  • 121
    • 59349103277 scopus 로고    scopus 로고
    • Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: Pharmacokinetics and safety
    • Monforte V, Ussetti P, López R, et al. Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety. J Heart Lung Transplant 2009; 28: 170-175.
    • (2009) J Heart Lung Transplant , vol.28 , pp. 170-175
    • Monforte, V.1    Ussetti, P.2    López, R.3
  • 122
    • 33645708611 scopus 로고    scopus 로고
    • Noncomparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation
    • Alexander BD, Dodds Ashley ES, Addison RM, et al. Noncomparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2006; 8: 13-20.
    • (2006) Transpl Infect Dis , vol.8 , pp. 13-20
    • Alexander, B.D.1    Dodds Ashley, E.S.2    Addison, R.M.3
  • 123
    • 42549085783 scopus 로고    scopus 로고
    • Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: A randomized, placebo-controlled trial
    • Rijnders BJ, Cornelissen JJ, Slobbe L, et al. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: A randomized, placebo-controlled trial. Clin Infect Dis 2008; 46: 1401-1408.
    • (2008) Clin Infect Dis , vol.46 , pp. 1401-1408
    • Rijnders, B.J.1    Cornelissen, J.J.2    Slobbe, L.3
  • 124
    • 29544451826 scopus 로고    scopus 로고
    • Contamination of the nebulization systems used in the prophylaxis with amphotericin B nebulized in lung transplantation
    • Monforte V, Román A, Gavaldà J, et al. Contamination of the nebulization systems used in the prophylaxis with amphotericin B nebulized in lung transplantation. Transplant Proc 2005; 37: 4056-4058.
    • (2005) Transplant Proc , vol.37 , pp. 4056-4058
    • Monforte, V.1    Román, A.2    Gavaldà, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.